Aurora Cannabis (TSE:ACB) Upgraded at BMO Capital Markets

BMO Capital Markets upgraded shares of Aurora Cannabis (TSE:ACB) to a hold rating in a research report report published on Wednesday morning,Zacks.com reports.

ACB has been the topic of several other reports. Canaccord Genuity Group cut their target price on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. TD dropped their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a report on Friday, June 12th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Aurora Cannabis has an average rating of “Moderate Buy” and an average target price of C$7.17.

Aurora Cannabis Trading Down 0.5%

TSE:ACB opened at C$4.15 on Wednesday. The firm has a market capitalization of C$257.06 million, a P/E ratio of -1.94 and a beta of 0.25. The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30. The company has a fifty day moving average of C$4.08 and a 200 day moving average of C$4.63. Aurora Cannabis has a 52 week low of C$3.59 and a 52 week high of C$9.33.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share (EPS) for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%.The firm had revenue of C$67.55 million during the quarter. On average, research analysts predict that Aurora Cannabis will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.